Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHematopoiesisHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsSurvival RateWhole-Body IrradiationInfectionTime FactorsSurvival AnalysisLymphoma, T-CellDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountHistocompatibility TestingPrednisoneCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineBlood Cell CountRecombinant ProteinsFollow-Up StudiesLeukemiaBone Marrow PurgingAntineoplastic AgentsLymphomaCytomegalovirus InfectionsBlood CellsProspective StudiesGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesImmunophenotypingMyelodysplastic SyndromesAnemia, AplasticBlood Transfusion, AutologousT-LymphocytesLiver TransplantationLymphocyte DepletionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukocytes, MononuclearHistiocytosis, Non-Langerhans-CellLivedo ReticularisOpportunistic InfectionsHematologic DiseasesBone MarrowHLA AntigensAnaplasmataceae InfectionsBlood DonorsCyclosporinePrognosisImmunosuppressionBreast NeoplasmsCell SeparationFlow Cytometry